GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine

Vaccine. 2007 Feb 26;25(10):1824-37. doi: 10.1016/j.vaccine.2006.10.060. Epub 2006 Nov 20.

Abstract

The present study evaluates immunogenicity and protection potency of a codon-optimized GRA1 DNA vaccine, wild type GRA1 DNA vaccine and an adjuvanted recombinant GRA1 protein vaccine candidate in BALB/c mice against lethal toxoplasmosis. Of the three GRA1 vaccines tested, the recombinant GRA1 protein vaccine results reveal significant increase in immune response and prolonged survival against acute toxoplasmosis compared to DNA vaccinations. Immune response and protection conferred by codon-optimized GRA1 DNA vaccine was slightly better than wild type GRA1 DNA vaccine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Protozoan / genetics
  • Antigens, Protozoan / immunology*
  • Base Sequence
  • Disease Models, Animal
  • Female
  • Mice
  • Mice, Inbred BALB C
  • Molecular Sequence Data
  • Recombinant Proteins / immunology
  • Toxoplasmosis / immunology
  • Toxoplasmosis / prevention & control*
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology*
  • Vaccines, Subunit / immunology*

Substances

  • Antigens, Protozoan
  • GRA1 antigen
  • Recombinant Proteins
  • Vaccines, DNA
  • Vaccines, Subunit